HOME >> BIOLOGY >> NEWS
Fox Chase Cancer Center receives grant to study possible link between measles vaccine and autism

PHILADELPHIA -- Glenn F. Rall, PhD, a member and noted scientist at Fox Chase Cancer Center has been awarded $189,000 from the M.I.N.D. Institute at U.C. Davis in California to study whether a link exists between the measles vaccine and the development of autism.

Few believe that the vaccine directly causes a child to develop autism, Rall says. However, we have an obligation as scientists to investigate this disease and any of its possible causes.

Recent reports have fueled a debate within both medical and parent communities concerning the safety of childhood vaccines and their possible link to autistic spectrum disorders (ASD).

However, says Rall, if such a link exists, it is not well defined. It is imperative that this issue be resolved, either leading to the development of safer vaccine alternatives, or reassuring parents of the safety of childhood vaccines.

Rall and his colleagues at Fox Chase Cancer Center will be using transgenic mouse models, that is, mice that are genetically engineered to be susceptible to measles virus infected in the brain. They will explore the hypothesis that the immune response of a newborn mouse is directly influenced by the exposure history of its mother. Neonatal mice that nursed on unexposed mothers cannot resolve the infection, he says. In contrast, weve found in our preliminary research that newborn mice nursed on mothers who were previously exposed to measles were protected from central nervous disease, suggesting that the maternal exposure history afforded protection to her offspring, Rall says. In some mice however, previous maternal exposure to measles leads to an absence of an appreciable immune response, which Rall and his colleagues believe may indicate a novel form of tolerance.

Autism is a neurological disorder that strikes one in 500 children, according to the National Institute of Child Health and Human Development. Autism ranges significantly in its severity, and is characteriz
'"/>

Contact: Sue Montgomery Madden
S_Madden@fccc.edu
215-728-7784
Fox Chase Cancer Center
10-Apr-2002


Page: 1 2

Related biology news :

1. Fox Chase Cancer Centers Alfred Knudson Jr. named 2004 Kyoto Prize winner
2. Fox Chase discovery may help physicians diagnose, treat devastating childhood disease
3. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
4. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
5. Fox Chase Cancer Center researchers identify significant smoking-induced genetic alteration
6. Fox Chase Cancer Center research reveals how COX-2 causes ovarian cancer
7. Fox Chase Cancer Center research shows kidney cancer can be diagnosed in urine
8. Fox Chase Cancer Center researcher develops new model for studying prions mad cow disease
9. Fox Chase Cancer Center study: Novel DNA-repair gene mutation can cause resistance to cancer drugs
10. NIH funds Breast Cancer and the Environmental Research Center at Fox Chase Cancer Center
11. Fox Chase Cancer Center researchers make significant discovery about function of p53

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2019)... ... July 31, 2019 , ... Molecular ... launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. ... FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering a ...
(Date:7/26/2019)... ANGELES (PRWEB) , ... July 26, 2019 , ... ... to announce an exclusive interview with Helius Medical Technologies CEO Phil Deschamps to ... trauma. , Helius Medical Technologies is a neurotech company in the ...
(Date:7/23/2019)... , ... July 23, 2019 , ... ... personalized, easy-to-understand, web-based genetic counseling, today announced that the company has expanded its ... MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The expanded content ...
Breaking Biology News(10 mins):
(Date:7/17/2019)... ... July 16, 2019 , ... Quidel is the market ... Information. Abbott, Roche and Siemens Healthineers and Response Biomedical also are among the ... Market for Point-of-Care (POC) Diagnostics . , Quidel is a market leader in ...
(Date:7/9/2019)... ... 2019 , ... Today, at the BIO World Congress on Industrial ... (NCGA) announced the winners of the Consider Corn Challenge II. Three winners were chosen, ... to produce biobased materials. , “Corn is a sustainable, abundant and affordable ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem ... Meet Biotech. The film focuses on regenerative veterinary medicine as a means of ... recently included in the Brentwood and Pacific Palisades International Film Festival in ...
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
Breaking Biology Technology:
Cached News: